Kiniksa Pharmaceuticals International Plc logo

Kiniksa Pharmaceuticals International Plc share price today

(KNSA)

Kiniksa Pharmaceuticals International Plc share price is $20.98 & ₹1,775.81 as on 6 Dec 2024, 2.30 'hrs' IST

$20.98

-0.15

(-0.71%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Kiniksa Pharmaceuticals International Plc share price in Dollar and Rupees. Guide to invest in Kiniksa Pharmaceuticals International Plc from India. Also see the sentimental analysis on Indian investors investing in Kiniksa Pharmaceuticals International Plc. Get details on the Indian mutual funds that are investing in Kiniksa Pharmaceuticals International Plc. Get Analyst recommendations and forecasts along with all the Kiniksa Pharmaceuticals International Plc's financials.

Kiniksa Pharmaceuticals International Plc share price movements

  • $20.76
    $21.26

    Day's Volatility :2.38%

  • $16.56
    $28.15

    52 Weeks Volatility :41.17%

Kiniksa Pharmaceuticals International Plc Returns

PeriodKiniksa Pharmaceuticals International PlcSector (Health Care)Index (Russel 2000)
3 Months
-15.84%
-5.7%
0.0%
6 Months
10.07%
-0.8%
0.0%
1 Year
17.87%
9.9%
0.0%
3 Years
56.8%
10.7%
-19.7%

Kiniksa Pharmaceuticals International Plc Key Statistics

in dollars & INR

Previous Close
$21.13
Open
$21.09
Today's High
$21.26
Today's Low
$20.755
Market Capitalization
$1.5B
Today's Volume
$212.8K
52 Week High
$28.15
52 Week Low
$16.56
Revenue TTM
$384.1M
EBITDA
$-24.4M
Earnings Per Share (EPS)
$-0.12
Profit Margin
-2.36%
Quarterly Earnings Growth YOY
5.5%
Return On Equity TTM
-2.15%

How to invest in Kiniksa Pharmaceuticals International Plc from India?

It is very easy for Indian residents to invest directly in Kiniksa Pharmaceuticals International Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kiniksa Pharmaceuticals International Plc stock in both rupees (INR) and dollars (USD). Search for Kiniksa Pharmaceuticals International Plc or KNSA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kiniksa Pharmaceuticals International Plc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kiniksa Pharmaceuticals International Plc shares which would translate to 0.040 fractional shares of Kiniksa Pharmaceuticals International Plc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Kiniksa Pharmaceuticals International Plc

-40%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Kiniksa Pharmaceuticals International Plc on INDmoney from India has reduced in the last 30 days as on Dec 6, 2024. -40% less investors are searching Kiniksa Pharmaceuticals International Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Kiniksa Pharmaceuticals International Plc

  • BlackRock Inc

    6.36%

  • Vanguard Group Inc

    4.57%

  • Fairmount Funds Management LLC

    4.44%

  • BRAIDWELL LP

    4.01%

  • Baker Bros Advisors LP

    3.90%

  • Rubric Capital Management LP

    3.35%

Analyst Recommendation on Kiniksa Pharmaceuticals International Plc

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Kiniksa Pharmaceuticals International Plc(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Kiniksa Pharmaceuticals International Plc

What analysts predicted

Upside of 71.59%

Current:

$20.98

Target:

$36.00

Insights on Kiniksa Pharmaceuticals International Plc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 79.85M → 112.21M (in $), with an average increase of 14.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.90M → -12.69M (in $), with an average decrease of 224.8% per quarter
  • Vs CTLT

    In the last 1 year, Catalent, Inc. has given 63.7% return, outperforming this stock by 41.5%

Kiniksa Pharmaceuticals International Plc Technicals Summary

Sell

Neutral

Buy

Kiniksa Pharmaceuticals International Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kiniksa Pharmaceuticals International Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kiniksa Pharmaceuticals International Plc
-8.9%
10.07%
17.87%
56.8%
84.52%
Neurocrine Biosciences Inc.
0.89%
-6.33%
5.35%
53.7%
11.14%
Haleon Plc Spon Ads
1.99%
14.2%
18.37%
31.31%
31.31%
Zoetis Inc.
2.58%
-1.22%
-3.88%
-22.57%
44.16%
Viatris Inc.
11.02%
23.11%
32.07%
3.95%
-21.11%
Catalent, Inc.
3.62%
10.16%
65.87%
-49.7%
19.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kiniksa Pharmaceuticals International Plc
143.0
NA
NA
-0.21
-0.02
-0.03
NA
6.06
Neurocrine Biosciences Inc.
33.98
33.98
0.3
6.54
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
28.41
29.36
1.74
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
32.98
32.98
2.44
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
224.4
NA
0.08
2.67
-0.04
0.02
0.04
16.58
Catalent, Inc.
211.02
NA
514.17
0.2
-0.11
0.0
NA
19.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kiniksa Pharmaceuticals International Plc
Buy
$1.5B
84.52%
143.0
-2.36%
Neurocrine Biosciences Inc.
Buy
$12.9B
11.14%
33.98
17.21%
Haleon Plc Spon Ads
Buy
$43.7B
31.31%
28.41
10.75%
Zoetis Inc.
Buy
$79.1B
44.16%
32.98
26.55%
Viatris Inc.
Hold
$15.1B
-21.11%
224.4
-5.87%
Catalent, Inc.
Hold
$11.2B
19.32%
211.02
-9.34%

About Kiniksa Pharmaceuticals International Plc

Organization
Kiniksa Pharmaceuticals International Plc
Employees
297
CEO
Mr. Sanj K. Patel
Industry
Health Technology

Management People of Kiniksa Pharmaceuticals International Plc

NameTitle
Mr. Sanj K. Patel
CEO & Chairman of the Board
Mr. Eben Tessari
Senior VP & COO
Dr. John F. Paolini FACC, M.D., Ph.D.
Senior VP & Chief Medical Officer
Mr. Mark Ragosa C.F.A.
Senior VP & CFO
Mr. Michael R. Megna CPA
Chief Accounting Officer & Group VP of Finance
Ms. Mei Jang
Senior Vice President of Technical Operations
Mr. Chad Morin
Senior VP & Chief Compliance Officer
Ms. Madelyn Demsky Zeylikman
SVP, General Counsel & Secretary
Mr. Carsten Boess M.B.A.
Executive Vice President of Corporate Affairs
Ms. Martina Struck Ph.D.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in Kiniksa Pharmaceuticals International Plc from India :

What is Kiniksa Pharmaceuticals International Plc share price today?

Kiniksa Pharmaceuticals International Plc (KNSA) share price today is $20.98.

Can Indians buy Kiniksa Pharmaceuticals International Plc shares?

Yes, Indians can invest in the Kiniksa Pharmaceuticals International Plc (KNSA) from India.

With INDmoney, you can buy Kiniksa Pharmaceuticals International Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kiniksa Pharmaceuticals International Plc at zero transaction cost.

How can I buy Kiniksa Pharmaceuticals International Plc shares from India?

It is very easy to buy Kiniksa Pharmaceuticals International Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kiniksa Pharmaceuticals International Plc be purchased?

Yes, you can buy fractional shares of Kiniksa Pharmaceuticals International Plc with INDmoney app.

What are the documents required to start investing in Kiniksa Pharmaceuticals International Plc stocks?

To start investing in Kiniksa Pharmaceuticals International Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kiniksa Pharmaceuticals International Plc

Today’s highest price of Kiniksa Pharmaceuticals International Plc (KNSA) is $21.26.

Today’s lowest price of Kiniksa Pharmaceuticals International Plc (KNSA) is $20.76.

What is today's market capitalisation of Kiniksa Pharmaceuticals International Plc

Today's market capitalisation of Kiniksa Pharmaceuticals International Plc KNSA is 1.5B

What is the 52 Week High and Low Range of Kiniksa Pharmaceuticals International Plc

  • 52 Week High

    $28.15

  • 52 Week Low

    $16.56

How much percentage Kiniksa Pharmaceuticals International Plc is down from its 52 Week High?

Kiniksa Pharmaceuticals International Plc (KNSA) share price is $20.98. It is down by 99% from its 52 Week High price of $28.15.

How much percentage Kiniksa Pharmaceuticals International Plc is up from its 52 Week low?

Kiniksa Pharmaceuticals International Plc (KNSA) share price is $20.98. It is up by 1% from its 52 Week Low price of $16.56.

What are the historical returns of Kiniksa Pharmaceuticals International Plc?

  • 1 Month Returns

    -8.9%

  • 3 Months Returns

    10.07%

  • 1 Year Returns

    17.87%

  • 5 Years Returns

    84.52%

Who is the Chief Executive Officer (CEO) of Kiniksa Pharmaceuticals International Plc

Mr. Sanj K. Patel is the current Chief Executive Officer (CEO) of Kiniksa Pharmaceuticals International Plc.